
BACKGROUND: Distal rectal transection during laparoscopic ultralow anterior resection or intersphincteric resection is technically demanding and may affect internal anal sphincter preservation, contributing to low anterior resection syndrome. Conformal resection after eversion with asymmetric twice stapling was developed to refine distal transection and stapled coloanal anastomosis in ultralow rectal cancer. OBJECTIVE: To compare perioperative, functional, and oncological outcomes between CREATE and the conventional double-stapling technique in ultralow rectal cancer. DESIGN: Multicenter retrospective cohort study based on prospectively maintained databases, with comparative analysis using propensity score matching. SETTINGS: Three tertiary colorectal surgery centers in China. PATIENTS: Between 2012 and 2021, 448 eligible patients with ultralow rectal cancer underwent laparoscopic ultralow anterior resection or intersphincteric resection (conformal resection after eversion with asymmetric twice stapling, n = 80; double-stapling technique, n = 368). After propensity score matching, 168 patients were included (conformal resection after eversion with asymmetric twice stapling, n = 60; double-stapling technique, n = 108). MAIN OUTCOME MEASURES: Operative variables, anastomotic leakage, anastomosis height, low anterior resection syndrome scores at 6, 12, and 24 months after stoma reversal, and 3-year disease-free survival and overall survival. RESULTS: After matching, conformal resection after eversion with asymmetric twice stapling showed a higher anastomosis (3.0 vs 2.0 cm from the anal verge, p < 0.001), a shorter distal resection margin (1.0 vs 1.2 cm, p < 0.001), and a shorter operative time (153 vs 175 min, p = 0.04). Anastomotic leakage occurred more frequently in the double-stapling technique group (1.7 vs 6.5%), although the difference was not statistically significant (p = 0.31). Low anterior resection syndrome outcomes were more favorable with conformal resection after eversion with asymmetric twice stapling at 6 months (major 42.9 vs 72.5%, p = 0.01) and 12 months (35.3 vs 66.7%, p = 0.007), with no differences at 24 months (p = 1.00). Three-year disease-free survival (88.4 vs 86.1%, p = 0.94) and overall survival (89.3 vs 91.5%, p = 0.60) were comparable between groups. LIMITATIONS: Selective eligibility for conformal resection after eversion with asymmetric twice stapling and functional assessment limited to patients who underwent stoma reversal and completed low anterior resection syndrome evaluations. CONCLUSIONS: CREATE was associated with a higher anastomosis and faster early functional recovery without increasing perioperative risk or compromising 3-year oncological outcomes. See Video Abstract.
BACKGROUND: Organ/space surgical site infections, including intra-abdominal abscesses and anastomotic leaks, are among the most severe complications after ileocolic resection for Crohn's disease. Biomarker cutoffs validated in oncological colorectal surgery may not translate to Crohn's disease because of modified inflammatory responses due to chronic inflammation and immunosuppressive therapies. OBJECTIVE: To identify early predictors of organ/space surgical site infections after ileocolic resection for Crohn's disease and to evaluate the performance of established biomarkers and specific predictive scores. DESIGN: Single-center retrospective observational study. SETTINGS: Tertiary referral center utilizing enhanced recovery after surgery pathways. PATIENTS: A total of 115 patients with histologically confirmed Crohn's disease. INTERVENTIONS: Ileocolic resection with primary anastomosis between January 2021 and May 2025. MAIN OUTCOME MEASURES: Development of organ/space surgical site infections within 30 days postoperatively, defined according to Centers for Disease Control/National Helathcare Safety Network criteria. RESULTS: Organ/space surgical site infections occurred in 15.7% (18/115) of patients. The C-reactive protein-to-albumin ratio on postoperative day 3 demonstrated excellent diagnostic accuracy (area under the curve = 0.932). At an optimal cutoff of 51.77, C-reactive protein-to-albumin ratio on postoperative day 3 yielded 94.1% sensitivity, 82.1% specificity, and a negative predictive value of 98.6%. C-reactive protein on postoperative day 3 also showed good accuracy (area under the curve = 0.871) with a negative predictive value of 97.1%. Procalcitonin and leucocyte-based indices showed poor-to-limited discrimination. LIMITATIONS: Retrospective, monocentric design without external validation. CONCLUSIONS: In Crohn's disease surgery, C-reactive protein-to-albumin ratio on postoperative Day 3 is a strong early predictor of organ/space surgical site infections. Together with C-reactive protein, its exceptionally high negative predictive value provides high "rule out" utility, supporting postoperative surveillance and safe discharge pathways. (See Video Abstract).